arbekacin has been researched along with Infections, Staphylococcal in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 48 (48.48) | 18.2507 |
2000's | 34 (34.34) | 29.6817 |
2010's | 17 (17.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higashide, M; Ichimura, S; Kumano, M; Kuroda, M; Ohkawa, S; Ohta, T; Omura, CT | 1 |
Panchal, G; Pandit, R; Sharma, A; Trailokya, A | 1 |
Hotta, K; Kondo, S | 1 |
Agarwal, R; Agrawal, RP; Basu, I; Bhalla, H; Bs, M; Das, C; Deb, AK; Dube, A; Kurlekar, U; Padhye, D; Pawar, R; Shahavi, V; Singh, RM; Srivastava, A; Srivastava, P | 1 |
Hamada, Y; Igarashi, M; Kasahara, K; Kimura, M; Kimura, T; Kobayashi, M; Matsumoto, K; Mikamo, H; Mochizuki, T; Nishi, Y; Ohmagari, N; Okada, K; Seki, M; Takahashi, Y; Takakura, S; Takesue, Y; Tanigawara, Y; Tokimatsu, I | 1 |
Akashi, K; Chong, Y; Harada, Y; Kadowaki, M; Miyake, N; Shimoda, S; Shimono, N; Uchida, Y | 1 |
Chung, KM; Hwang, JH; Kim, JS; Lee, CS; Lee, EJ; Lee, JH; Moon, MK; Won, KS; Yoon, YJ | 1 |
Sato, K | 1 |
Hatta, Y; Hirabayashi, Y; Hojo, A; Iriyama, N; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Ohtake, S; Sakagami, M; Takahashi, H; Takei, M; Uchino, Y | 1 |
Hagihara, M; Hamada, Y; Hirai, J; Kato, H; Koizumi, Y; Matsuura, K; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Yamagishi, Y | 1 |
Ariyoshi, N; Hasegawa, A; Hashimoto, N; Igari, H; Kitada, M; Nakamura, H; Nakamura, Y; Nakasa, H; Nakazawa, K; Nomura, F; Sato, T; Watanabe, A; Watanabe, M; Yokoyama, I | 1 |
Aibiki, M; Fukuoka, N | 1 |
Aoyama, T; Hayashi, H; Iwahori, T; Kawai, M; Matsumoto, Y; Matsuzaki, T; Mizuno, Y; Saito, A | 1 |
Abe, Y; Akiyama, O; Ito, M; Okura, H; Suga, Y; Tsutsumi, S; Yasumoto, Y | 1 |
Fukushima, T; Hirose, Y; Iwao, H; Masaki, Y; Miki, M; Nakazima, A; Sakai, T; Sawaki, T; Tanaka, M; Umehara, H | 1 |
Hagane, K; Hanaki, H; Hashimoto, T; Ikeda-Dantsuji, Y; Ishizaki, A; Kageyama, Y; Kawaguchi, T; Kawajiri, H; Ono, T; Sato, S; Sugahara, K; Sunakawa, K; Tachihara-Sato, R; Takahashi, Y; Tamura, A; Yamaguchi, Y; Yanagisawa, C; Yanagisawa, T; Yazaki, H | 1 |
Furugaki, K; Oyama, M; Yoshida, J | 1 |
Kinoshita, D | 1 |
Hamada, Y; Koyama, I; Kuroyama, M; Sunakawa, K; Tamura, K; Yago, K | 1 |
Hwang, JH; Kim, JS; Lee, CS; Lee, JH; Moon, MK; Won, KS | 1 |
Fukuda, Y; Hashiguchi, K; Imamura, Y; Inoue, Y; Izumikawa, K; Kakeya, H; Kobayashi, T; Kohno, S; Kondo, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Yamamoto, Y; Yanagihara, K | 1 |
Miyake, N; Nagasaki, Y; Shimono, N; To, K | 1 |
Miyoshi, K; Miyoshi, S; Oto, T; Soh, J; Sugimoto, S; Toyooka, S; Ueno, T; Yamane, M | 1 |
Niki, Y | 1 |
Fujita, A; Inagaki, K; Inatomi, T; Kinoshita, S; Koizumi, N; Sano, Y; Sotozono, C | 1 |
Suzuki, K | 1 |
Choi, JH; Choi, SM; Chun, HS; Kang, MW; Lee, DG; Shin, WS; Yim, DS; Yoo, JH | 1 |
Endo, K; Fukuda, M; Hashikita, G; Itabashi, A; Maesaki, S; Tominaga, K; Yamazaki, T | 1 |
Hikida, M; Kawabata, T; Maebashi, K; Niida, M; Sakakibara, S; Takata, T | 1 |
Morikawa, K; Nonaka, M; Torii, I; Yoshikawa, Y | 2 |
Ebisu, R; Minowa, H; Takahashi, Y; Uchida, Y; Yoshida, K; Yoshioka, A | 1 |
Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A; Shimizu, M | 1 |
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH | 1 |
Hotta, K; Ishikawa, J; Ishino, K; Nakajima, M; Saito, F; Tsuchizaki, N | 1 |
Aikawa, N; Kaku, M; Sato, R; Shimizu, K; Tanigawara, Y | 1 |
Aikawa, N; Kaku, M; Morita, K; Sato, R; Shimizu, K; Tanigawara, Y | 1 |
Hotta, K; Ishikawa, J; Ishino, K; Tsuchizaki, N | 1 |
Hayashi, I; Ida, T; Kato, Y; Maebashi, K; Sakurai, M; Shiotani, J; Suzuki, T | 1 |
Hirano, M; Katayama, S; Kawada, K; Momose, Y; Nishizawa, K; Takehira, R; Yamamura, S | 1 |
Chong, Y; Kim, CK; Lee, H; Lee, J; Lee, K; Roh, KH; Yong, D; Yum, JH | 1 |
Aoyama, T; Hayashi, H; Matsumoto, Y; Matsuzaki, T; Saito, A | 1 |
Araki, H; Inoue, T; Murase, M; Nishimiya, T; Otsuka, T; Suemaru, K; Tanaka, A | 1 |
Hamada, T; Harada, R; Hata, E; Miyamoto, H; Sakao, Y | 1 |
Hashimoto, H; Hayashi, I; Inoue, M | 3 |
Ida, T; Inoue, M; Nonoyama, M; Okamoto, R | 1 |
Hayashi, I; Inoue, M | 1 |
Hayashi, I; Ichiki, M; Ishikawa, T; Karato, A; Niida, M; Ogawa, M; Sakurai, M; Sekine, I; Shiotani, J; Yoshida, T | 1 |
Hashimoto, H | 1 |
Hasobe, T; Ida, T; Inoue, M; Nonoyama, M; Okamoto, R; Okubo, T; Shimauchi, C | 1 |
Ishii, T; Orikasa, Y; Takase, Y; Takayama, Y | 1 |
Goto, S; Sugano, T; Takada, T; Takase, Y; Tsuji, A; Yamaguchi, K; Yoshida, T | 1 |
Araake, M; Mitomi, N; Niizato, T; Shimizu, K; Totsuka, K | 1 |
Azuma, E; Nasuhara, K; Saijo, N; Saito, I; Shinohara, M; Sone, H; Takatsuka, K; Takatsuka, N; Teraoka, M; Tokita, S | 1 |
Ichiyama, S; Shimokata, K | 1 |
Imai, T; Ito, A; Matsumoto, F; Odagiri, S; Sakurai, I; Sugiyama, M; Sumitomo, M; Suzuki, M; Takahashi, K; Yoshikawa, K | 1 |
Hamazaki, H; Hasegawa, H; Horiuchi, A; Kageyama, T; Kanayama, Y; Kitani, T; Masaoka, T; Sugiyama, H; Tatsumi, N; Uchino, H | 1 |
Arita, K; Kodama, T; Konishi, F; Kurimura, T; Kuwabara, M; Miyazawa, T; Miyoshi, N; Nakai, S; Santoh, T; Yokoyama, T | 1 |
Goto, A; Hasegawa, S; Irokawa, M; Ishida, H; Iwata, S; Nakai, T; Otsuka, M; Sawahata, T; Shinohara, Y; Yoshizawa, Y | 1 |
Fujioka, Y; Houjou, S; Iida-Tanaka, K; Miki, S; Nakamura, Y; Takahara, J; Takahashi, T; Tamura, T; Tanaka, T; Yamanoi, Y | 1 |
Arakawa, K; Hattori, F; Hoshino, H; Kono, K; Minamikawa, H; Miyake, S; Sato, M; Takeda, S; Tanaka, H; Tatara, I | 1 |
Hara, K; Hashimoto, A; Inoue, Y; Kaku, M; Koga, H; Kohno, S; Ohtsubo, T; Sugiyama, H; Taira, K; Tomono, K | 1 |
Fujita, K; Kato, H; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
Hori, K; Ishikawa, S; Mashita, K; Mizuno, A; Shinagawa, N; Yura, J | 1 |
Fujimoto, M; Hirata, S; Kaji, M; Kinoshita, H; Morimoto, K; Nakatani, S; Tamate, S; Ueda, T; Yamazaki, O | 1 |
Kasitani, M; Konishi, R; Kouno, N; Noguchi, K; Ochiai, M; Ohkouchi, N; Ohnishi, H; Shimada, K; Takifuji, K; Tanimura, H | 1 |
Abe, T; Fujii, R; Fujita, K; Meguro, H; Mikuni, K; Sakai, T; Sakata, Y; Tajima, T; Terashima, I; Watanabe, N | 1 |
Tsuji, A | 1 |
Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
Akahane, T; Furihata, K; Furuwatari, C; Katsuyama, T; Kawakami, Y; Matsumoto, H; Okimura, Y | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Yokota, N | 1 |
Fuse, H; Katayama, T; Kazama, T; Muraishi, Y; Okumura, A; Sakamoto, M; Tsuritani, S | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Suzuki, K; Suzuki, Y; Yokota, N | 1 |
Deguchi, K; Fukumoto, T; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nakazawa, A; Nishinari, C; Suzuki, Y | 1 |
Fujita, T; Fukai, H; Kayama, T; Nakai, O; Sato, I; Sobue, H | 1 |
Fujita, J; Hojo, S; Ichiyama, S; Kawanishi, K; Miyawaki, H; Negayama, K; Obayashi, Y; Takahara, J; Takashima, C; Tanabe, T; Yamaji, Y | 1 |
Hanaki, H; Hiramatsu, K; Ino, T; Oguri, T; Tenover, FC; Yabuta, K | 1 |
Itokazu, M; Kato, N; Ohno, T; Tanemori, T; Wada, E; Watanabe, K | 1 |
Hiramatsu, K; Inaba, Y | 1 |
Fukayama, M | 1 |
Itokazu, M; Kumazawa, S; Matsunaga, T; Oka, M | 1 |
Arakawa, K; Kono, K; Takeda, S; Yasunaka, K | 1 |
Aihara, Y; Fukamachi, K; Hori, T; Imamura, T; Kasuya, H; Kawashima, A; Kikuchi, K; Ochiai, T; Shiseki, M; Tozuka, K; Yamaguchi, K | 1 |
Akins, RL; Rybak, MJ | 1 |
Ishikawa, S; Koyano, T; Morishita, Y; Noda, D; Ooki, S; Shimizu, H; Takahashi, T | 1 |
Abe, T; Fujimura, S; Gomi, K; Kobayashi, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
Cordeiro, JC; Miranda, EA; Reis, AO; Sader, HS | 1 |
Araake, M; Hanaki, H; Hiramatsu, K; Miyata, A; Ogawa, H | 1 |
Hanaki, H | 1 |
Watanabe, A | 1 |
Irifune, A; Kaneda, A; Mitoh, Y; Shiigai, T; Shintani, S; Tanaka, H; Udono, H | 1 |
Arakawa, M; kawashima, T; Tsukasa, H; Wada, K | 1 |
Nitta, Y; Sunakawa, K; Yokota, T | 1 |
Inamatsu, T | 1 |
Kobayashi, Y | 1 |
Niijima, T | 1 |
11 review(s) available for arbekacin and Infections, Staphylococcal
Article | Year |
---|---|
Kanamycin and its derivative, arbekacin: significance and impact.
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Humans; Kanamycin; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2018 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
[Revaluation of current antimicrobials. Series 17: Arbekacin sulfate].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Drug resistance of methicillin-resistant Staphylococcus aureus (MRSA) in Japan until 1993].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Gram-positive cocci (include MRSA)].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1994 |
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple; Drug Therapy, Combination; Genotype; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1998 |
[Methicillin resistant Staphylococcus aureus infection].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
[MRSA septicemia caused by an infected pacemaker lead: a case report with a review of Japanese literatures].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cardiopulmonary Bypass; Dibekacin; Drug Therapy, Combination; Female; Humans; Methicillin Resistance; Middle Aged; Minocycline; Pacemaker, Artificial; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2000 |
[MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacterial Proteins; Bacterial Toxins; Dibekacin; Enterotoxins; Gentian Violet; Humans; Immunoglobulins, Intravenous; Methicillin Resistance; Repressor Proteins; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
[New antimicrobial agent series XL: arbekacin].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Humans; In Vitro Techniques; Methicillin Resistance; Mice; Staphylococcal Infections; Staphylococcus aureus | 1991 |
20 trial(s) available for arbekacin and Infections, Staphylococcal
Article | Year |
---|---|
A Multicentre, Open label, Randomized, Comparative, Parallel Group, Active-controlled, Phase III Clinical Trial to Evaluate Safety and Efficacy of Arbekacin Sulphate Injection versus Vancomycin Injection in Patients Diagnosed with MRSA Infection.
Topics: Anti-Bacterial Agents; Dibekacin; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2018 |
Comparison of Arbekacin and Vancomycin in Treatment of Chronic Suppurative Otitis Media by Methicillin Resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Otitis Media, Suppurative; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Topics: Adult; Aged; Anti-Infective Agents; beta-Lactams; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome | 2016 |
Recommended dose of arbekacin, an aminoglycoside against methicillin-resistant Staphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Illness; Data Interpretation, Statistical; Dibekacin; Dose-Response Relationship, Drug; Female; Fluorescence Polarization Immunoassay; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Tissue Distribution | 2008 |
The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Treatment Outcome | 2012 |
Factors influencing neonatal therapeutic effect of anti-MRSA drugs.
Topics: Alanine Transaminase; Albumins; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Blood Urea Nitrogen; C-Reactive Protein; Creatinine; Dibekacin; Drug Monitoring; Humans; Infant; Infant, Newborn; Logistic Models; Methicillin Resistance; Odds Ratio; Platelet Count; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin | 2005 |
Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Child; Dibekacin; Drug Monitoring; Female; Humans; Kidney Diseases; Kidney Function Tests; Logistic Models; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Risk; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections.
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections | 1994 |
[Laboratory and clinical studies on combined effects of fosfomycin plus sulbactam/cefoperazone for mixed infections of MRSA and Pseudomonas aeruginosa].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1994 |
[Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man].
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Administration Schedule; Guinea Pigs; Humans; Infusions, Intravenous; Kidney; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Coagulase; Dibekacin; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin on MRSA infections].
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[An evaluation study on arbekacin for MRSA-infectious diseases including pneumonia, septicemia and others].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Kidney; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Child, Preschool; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infant; Japan; Lactams; Male; Methicillin Resistance; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Dibekacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Clinical studies of arbekacin sulfate in the pediatric field].
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Dibekacin; Female; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1994 |
68 other study(ies) available for arbekacin and Infections, Staphylococcal
Article | Year |
---|---|
Methicillin-resistant Staphylococcus saprophyticus isolates carrying staphylococcal cassette chromosome mec have emerged in urogenital tract infections.
Topics: Bacterial Proteins; Chromosomes, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methicillin Resistance; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections | 2008 |
Arbekacin - A Novel Antibiotic for Critical Infections.
Topics: Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Humans; India; Japan; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2019 |
Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.
Topics: Anti-Infective Agents; Consensus; Dibekacin; Drug Monitoring; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2014 |
Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dibekacin; DNA Transposable Elements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA; Staphylococcal Infections; Transcriptional Activation | 2014 |
External ocular infections due to methicillin-resistant Staphylococcus aureus and medical history.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Conjunctivitis; Cross-Sectional Studies; Dacryocystitis; Dibekacin; Eye Infections, Bacterial; Female; Humans; Infant; Keratitis, Herpetic; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2015 |
Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Biological; Retrospective Studies; Staphylococcal Infections; Young Adult | 2016 |
[Appropriate use of anti-methicillin-resistant Staphylococcus aureus agents in a retrospective study].
Topics: Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2008 |
[Analysis of factors affecting long-term administration of anti-methicillin resistant Staphylococcus aureus (MRSA) drugs].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dibekacin; Humans; Immunosuppressive Agents; Methicillin Resistance; Multivariate Analysis; Serum Albumin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2009 |
[Case with large abdominal abscess associated with a ventriculoperitoneal shunt].
Topics: Abdominal Abscess; Anti-Bacterial Agents; Brain Abscess; Child; Dibekacin; Drainage; Female; Humans; Immunocompromised Host; Staphylococcal Infections; Vancomycin; Ventriculoperitoneal Shunt | 2009 |
MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.
Topics: Abscess; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Dibekacin; Fever; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pyomyositis; Remission Induction; Staphylococcal Infections | 2009 |
Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2009 |
Perioperative antimicrobials in chest surgery patients positive for methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Dibekacin; Drug Administration Schedule; Guideline Adherence; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Perioperative Care; Practice Guidelines as Topic; Pulmonary Surgical Procedures; Staphylococcal Infections; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin | 2010 |
[Evaluation of once a day of arbekacin administration to neonates as a new object of peak concentration].
Topics: Anti-Infective Agents; Dibekacin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections | 2010 |
Clinical efficacy of arbekacin for Gram-negative bacteria.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coinfection; Dibekacin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections | 2011 |
The usefulness of arbekacin compared to vancomycin.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Dibekacin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Successful combination therapy with vancomycin and arbekacin against infective endocarditis caused by MRSA.
Topics: Adult; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Drug Therapy, Combination; Endocarditis; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Dibekacin; Empyema, Pleural; Female; Follow-Up Studies; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonectomy; Postoperative Complications; Retrospective Studies; Staphylococcal Infections; Therapeutic Irrigation; Thoracic Cavity; Treatment Outcome | 2012 |
Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Eye Infections, Bacterial; Female; Humans; Incidence; Keratitis; Male; Methicillin; Methicillin Resistance; Middle Aged; Ofloxacin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 2002 |
Efficacy and safety of arbekacin for staphylococcal infection in the NICU.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cross Infection; Dibekacin; Evoked Potentials, Auditory, Brain Stem; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin Resistance; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Blood Coagulation; Colony Count, Microbial; Dibekacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fibrin; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Topics: Aminoglycosides; Cross Infection; Dibekacin; Drug Resistance, Bacterial; Epidemiologic Studies; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2004 |
[Combined effects of arbekacin with biapenem against in vitro and in vivo model of a mixture of MRSA and Pseudomonas aeruginosa].
Topics: Aminoglycosides; Animals; Anti-Infective Agents; Dibekacin; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins | 2004 |
Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Dibekacin; Disease Models, Animal; Drug Synergism; Fosfomycin; Granuloma; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Dosage regimen of arbekacin for methicillin-resistant Staphylococcus aureus infection in newborns and infants.
Topics: Aminoglycosides; Biological Availability; Birth Weight; Dibekacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Maximum Tolerated Dose; Methicillin Resistance; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
Effect of arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Biofilms; Dibekacin; Disease Models, Animal; Granuloma; Humans; Male; Methicillin Resistance; Microscopy, Electron, Scanning; Necrosis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2004 |
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin | 2006 |
Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Coagulase; Deoxyribonucleases, Type II Site-Specific; Dibekacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enzymes; Hospitals; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus | 2006 |
Population pharmacokinetics of Arbekacin in patients infected with methicillin-resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Child; Dibekacin; Dose-Response Relationship, Drug; Female; Humans; Male; Methicillin Resistance; Middle Aged; Models, Statistical; Population; Reproducibility of Results; Sepsis; Staphylococcal Infections | 2006 |
Usefulness of PCR-restriction fragment length polymorphism typing of the coagulase gene to discriminate arbekacin-resistant methicillin-resistant Staphylococcus aureus strains.
Topics: Aminoglycosides; Anti-Infective Agents; Bacterial Typing Techniques; Coagulase; Dibekacin; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
Topics: Aged; Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; Female; Glycopeptides; Humans; Imipenem; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Mutation; Oxacillin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Prediction of aminoglycoside response against methicillin-resistant Staphylococcus aureus infection in burn patients by artificial neural network modeling.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Blood Glucose; Burns; Creatinine; Dibekacin; Female; Forecasting; Humans; Logistic Models; Male; Methicillin Resistance; Middle Aged; Neural Networks, Computer; Retrospective Studies; Severity of Illness Index; Skin Transplantation; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
[In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
Topics: Anti-Bacterial Agents; Dibekacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2007 |
[Analysis of factors in selecting anti-methicillin-resistant Staphylococcus aureus drugs by doctors].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Monitoring; Humans; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2008 |
Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Creatinine; Cystatin C; Cystatins; Dibekacin; Drug Monitoring; Female; Glomerular Filtration Rate; Hospitals, University; Humans; Male; Methicillin Resistance; Renal Insufficiency; Staphylococcal Infections | 2008 |
[Combination therapy with arbekacin and fosfomycin against postoperative severe mixed-pneumonia of MRSA in primary lung cancer patients].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Immunocompromised Host; Lactams; Lung Neoplasms; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Postoperative Complications; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1995 |
Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Gentamicins; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
[Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Questionnaires regarding MRSA in Japan].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Japan; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires | 1994 |
[Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1994 |
[Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Computer Simulation; Dibekacin; Gentamicins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Clinical efficacy of arbekacin in deep MRSA infection. Including follow-up study after the termination of chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cilastatin; Dibekacin; Female; Follow-Up Studies; Humans; Imipenem; Kidney; Male; Methicillin Resistance; Middle Aged; Minocycline; Recurrence; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Fosfomycin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 1994 |
[MRSA infections in surgery].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Minocycline; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cefotiam; Cilastatin; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
[Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery].
Topics: Administration, Inhalation; Administration, Topical; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Methicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1994 |
In vitro activity of arbekacin against clinical isolates of methicillin-resistant Staphylococcus aureus in a hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 1994 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Child; Dibekacin; Humans; Kanamycin Resistance; Methicillin Resistance; Pneumonia; Respiratory System; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[Clinical studies on methicillin-resistant Staphylococcus aureus (MRSA) infections].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Enterocolitis; Female; Humans; Immunocompromised Host; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Urinary Bladder Neoplasms; Vancomycin | 1993 |
[Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Methicillin Resistance; Serotyping; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1997 |
MRSA meningitis and intrathecal injection of arbekacin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Female; Humans; Injections, Spinal; Meningitis, Bacterial; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Methicillin Resistance; Middle Aged; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 1997 |
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Humans; Infant; Male; Methicillin Resistance; Microbial Sensitivity Tests; Pulmonary Atresia; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin; Wounds and Injuries | 1997 |
Antibiotic-loaded hydroxyapatite blocks in the treatment of experimental osteomyelitis in rats.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dibekacin; Drug Delivery Systems; Drug Implants; Hydroxyapatites; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia | 1997 |
Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block.
Topics: Adolescent; Alcaligenes; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Delivery Systems; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tuberculosis | 1994 |
Methicillin-resistant Staphylococcus aureus (MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the Fukuoka city area.
Topics: Ambulatory Care Facilities; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cluster Analysis; Coagulase; Dibekacin; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
[Two cases of methicillin-resistant Staphylococcus aureus (MRSA) sepsis following craniotomy].
Topics: Adult; Aged; Alanine; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Craniotomy; Dibekacin; Drug Therapy, Combination; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Methicillin Resistance; Postoperative Complications; Sepsis; Staphylococcal Infections; Sulbactam; Thienamycins; Treatment Outcome; Vancomycin | 2000 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus | 2000 |
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
Topics: Aminoglycosides; Anti-Bacterial Agents; Brazil; Dibekacin; Drug Resistance, Microbial; Hospitals; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2001 |
[Effect of arbekacin on the production of toxic shock syndrome toxin 1 by methicillin-resistant Staphylococcus aureus].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Blood; Culture Media; Depression, Chemical; Dibekacin; Dose-Response Relationship, Drug; Enterotoxins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Teicoplanin; Vancomycin | 2001 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
Iatrogenic acute spinal epidural abscess with septic meningitis: MR findings.
Topics: Abscess; Acyclovir; Aged; Aminoglycosides; Anesthesia, Epidural; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Epidural Space; Female; Herpes Zoster; Humans; Iatrogenic Disease; Imipenem; Magnetic Resonance Imaging; Meningitis, Bacterial; Myelography; Neuralgia; Palliative Care; Spinal Diseases; Staphylococcal Infections | 1992 |
[Septicemia caused by MRSA].
Topics: Aminoglycosides; Anti-Bacterial Agents; Catheterization; Dibekacin; Equipment Contamination; Humans; Methicillin Resistance; Prognosis; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[MRSA infections in neonates and premature infants].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Dibekacin; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Chemotherapy of MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Combinations; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Vancomycin | 1992 |
[Vancomycin and arbekacin, drugs of treatment for MRSA infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |